Page last updated: 2024-10-27

gemfibrozil and Syndrome

gemfibrozil has been researched along with Syndrome in 2 studies

Syndrome: A characteristic symptom complex.

Research Excerpts

ExcerptRelevanceReference
"It is not known whether PPAR-alpha agonist gemfibrozil is able to exert rapidly its lipid modulating, potential antiinflammatory and antithrombotic effects in patients with non-ST elevation acute coronary syndrome (NSTEACS), as some other lipid lowering drugs e."9.12[Early use of gemfibrozil in patients with non ST Elevation acute coronary syndrome. Changes of markers of inflammation and von Willebrand factor]. ( Deev, AD; Gratsianskiĭ, NA; Pokrovskaia, EV; Vaulin, NA, 2006)
"It is not known whether PPAR-alpha agonist gemfibrozil is able to exert rapidly its lipid modulating, potential antiinflammatory and antithrombotic effects in patients with non-ST elevation acute coronary syndrome (NSTEACS), as some other lipid lowering drugs e."5.12[Early use of gemfibrozil in patients with non ST Elevation acute coronary syndrome. Changes of markers of inflammation and von Willebrand factor]. ( Deev, AD; Gratsianskiĭ, NA; Pokrovskaia, EV; Vaulin, NA, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vaulin, NA1
Pokrovskaia, EV1
Deev, AD1
Gratsianskiĭ, NA1
Simo, IE1
Yakichuk, JA1
Ooi, TC1

Trials

2 trials available for gemfibrozil and Syndrome

ArticleYear
[Early use of gemfibrozil in patients with non ST Elevation acute coronary syndrome. Changes of markers of inflammation and von Willebrand factor].
    Kardiologiia, 2006, Volume: 46, Issue:6

    Topics: Acute Disease; Aged; Biomarkers; C-Reactive Protein; CD40 Ligand; Coronary Disease; Electrocardiogra

2006
Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome.
    Atherosclerosis, 1993, Volume: 100, Issue:1

    Topics: Adult; Dietary Fats; Double-Blind Method; Eating; Fasting; Gemfibrozil; Humans; Hypertriglyceridemia

1993